Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
Executive Q&A - A Strategic Acquisition: Insights and Ideas
An interview with Brian Morrissey, General Manager of Gaelic Laboratories, which has acquired Athlone Laboratories in a strategic deal that typifies the current pharma M&A landscape and puts all of Ireland’s Beta-Lactam manufacturing capacity under one ownership umbrella. read more
Horizon Lines: A Quarterly Review of NDAs – July-September 2025
This quarterly review on New Drug Applications contains data for applications approved during the third quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 48 applications were approved by the FDA during these three months. read more
Prefilled Syringes: Sterile Drug Delivery, Market Dynamics, CDMO Partnerships, and Market Outlook to 2030
The global pharmaceutical sterile and prefilled syringe market has experienced remarkable growth in recent years, fueled by technological advances and evolving therapeutic needs. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Agilent and Veeda Lifesciences Collaborate to Accelerate GLP-1 and Complex Biologics Development Services
Thursday, May 14, 2026
Agilent Technologies announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory-aligned analytical and bioanalytical ... read more
Piramal Pharma Solutions Opens Payload-Linker Suite at its Riverview, Michigan Facility
Wednesday, May 13, 2026
This launch is a key element of the company's broader $90 million investment plan to extend U.S.-based manufacturing capabilities, announced last year read more
OrganaBio Acquires Excellos Operating Assets
Wednesday, May 13, 2026
OrganaBio has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract ... read more
Vetter Starts Construction of a New Production Site in Germany
Wednesday, May 13, 2026
Vetter announced the start of construction on its new site in Saarlouis. During the first construction phase, the company will build a state-of-the-... read more
Avid Bioservices Appoints Chief Commercial Officer
Tuesday, May 12, 2026
Avid Bioservices announced the appointment of Kerri McCullough Wood as Chief Commercial Officer. read more